13 recruiting, 9 completed, 4 unknown, 3 active not recruiting. 21 Phase 1, 10 Phase 2, 6 Not applicable, 1 Phase 3.
Follow Solid Carcinoma: new trials by email Literature Review of Solid Carcinoma trials Research Report on Solid Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Imaging Study of [89Zr]DFO-YS5 for Cancer Detection [89Zr]DFO-YS5, Positron Emission Tomography (PET)-Computerized tomography (CT) - Bladder Cancer, Nerve Sheath Tumor | Phase 1 | Recruiting | Robert Flavell, MD, PhD | 40 | 2026-06-15 | 2026-10-01 |
| FORTRAS: A Study of MSK-TCR5 in People With Solid Tumor Cancers MSK-TCR5 - Solid Tumor, Solid Carcinoma | Phase 1 | Recruiting | Memorial Sloan Kettering Cancer Center | 16 | 2026-06-09 | 2026-11-02 |
| Imaging of Solid Tumors Using 18F-TRX 18F-TRX, Positron Emission Tomography (PET)/Computerized tomography (CT), Tumor Biopsy - Solid Tumor, Solid Carcinoma | Phase 1 | Recruiting | Rahul Aggarwal | 56 | 2025-07-03 | 2026-07-23 |
| PET [89Zr]DFO-starPEG in Solid Tumors 89-zr-dfo-star polyethylene glycol (StarPEG), Whole Body Positron Emission Tomography (PET), Specimen Collection - Solid Tumor, Solid Carcinoma | Phase 1 | Recruiting | Robert Flavell, MD, PhD | 13 | 2025-06-02 | 2026-06-05 |
| A Study of DM002 in Patients With Advanced Solid Tumors DM002 - Ovarian Neoplasms, Prostatic Neoplasms | Phase 1 / Phase 2 | Recruiting | Xadcera Biopharmaceutical (Suzhou) Co., Ltd. | 280 | 2025-02-17 | 2026-08-07 |
| Trop2-targeted immunoPET Imaging of Solid Tumors [68Ga]Ga-NOTA-T4, [68Ga]Ga-NOTA-RT4, [18F]F-RESCA-T4 - Solid Tumor, Solid Carcinoma | Phase 2 / Phase 3 | Recruiting | RenJi Hospital | 400 | 2024-12-23 | 2026-05-29 |
| A Study of DM005 in Patients With Advanced Solid Tumors DM005 - Carcinoma, Non-Small-Cell Lung, Squamous Cell Carcinoma of Head and Neck | Phase 1 / Phase 2 | Recruiting | Doma Biopharmaceutical（Suzhou）Co., Ltd. | 208 | 2024-10-31 | 2026-08-07 |
| A Study of DM001 in Patients With Advanced Solid Tumors DM001 - Breast Neoplasms, Carcinoma, Non-Small-Cell Lung | Phase 1 | Active not recruiting | Xadcera Biopharmaceutical (Suzhou) Co., Ltd. | 128 | 2024-10-24 | 2026-08-28 |
| A Study of Avutometinib for People With Solid Tumor Cancers Avutometinib - Refractory Cancer, CNS Tumors | Phase 1 | Completed | Memorial Sloan Kettering Cancer Center | 3 | 2023-10-20 | 2026-11-04 |
| Thrombin Generation and Prediction of Thromboembolic Events in Oncology Patients at Risk thrombogram - Solid Carcinoma | Not applicable | Recruiting | Institut Cancerologie de l'Ouest | 200 | 2023-09-12 | 2026-02-17 |
| A Study of AZD1390 and Stereotactic Body Radiotherapy (SBRT) for People With Metastatic Solid Tumor Cancer AZD1390, Stereotactic Body Radiotherapy - Solid Tumor, Metastatic Solid Tumor | Phase 1 | Active not recruiting | Memorial Sloan Kettering Cancer Center | 54 | 2023-05-17 | 2026-05-18 |
| Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies S241656, FOLFOX6/FOLFOX7, FOLFIRI - Non-small Cell Lung Cancer, Histiocytic Neoplasm | Phase 1 / Phase 2 | Recruiting | Institut de Recherches Internationales Servier | 554 | 2023-04-18 | 2026-10-13 |
| FMT With Nivolumab in Patients With Advanced Solid Cancers Who Have Progressed During Anti-PD-(L)1 Therapy fecal microbiota transplantation with Nivolumab - Solid Carcinoma | Not applicable | Recruiting | Asan Medical Center | 50 | 2023-03-08 | 2025-12-03 |
| PRE-ISPY Phase I/II Oncology Platform Program ALX148, Fam-Trastuzumab Deruxtecan-Nxki, Zanidatamab - HER2-positive Breast Cancer, Metastatic Cancer | Phase 1 / Phase 2 | Recruiting | QuantumLeap Healthcare Collaborative | 280 | 2023-02-15 | 2026-09-30 |
| Oral AMXT 1501 Dicaprate in Combination With IV DFMO AMXT1501, DFMO - Cancer, Solid Tumor | Phase 1 / Phase 2 | Terminated | Aminex Therapeutics, Inc. | 15 | 2022-11-29 | 2024-12-24 |
| A Study of CF33-hNIS (VAXINIA), an Oncolytic Virus, as Monotherapy or in Combination With Pembrolizumab in Adults With Metastatic or Advanced Solid Tumors CF33-hNIS, Pembrolizumab, Modified FOLFOX - Solid Tumor, Solid Carcinoma | Phase 1 | Terminated | Imugene Limited | 66 | 2022-05-17 | 2026-03-06 |
| A Study of Mirdametinib on Its Own or in Combination With Fulvestrant in People With Solid Tumor Cancer Mirdametinib, Fulvestrant - Breast Cancer, Breast Cancer Stage IV | Phase 1 / Phase 2 | Completed | Memorial Sloan Kettering Cancer Center | 6 | 2021-09-14 | 2025-05-23 |
| Psychological Care of Oncology Patients With Post-traumatic Stress in the Context of a COVID-19 Psychological support - Solid Carcinoma, Post Traumatic Stress Disorder | Not applicable | Completed | Centre Francois Baclesse | 29 | 2021-06-18 | 2026-07-31 |
| A Study of Romiplostim to Prevent Low Platelet Counts in Children and Young Adults Receiving Chemotherapy for Solid Tumors Romiplostim - Solid Tumor, Solid Tumor, Childhood | Phase 2 | Terminated | Memorial Sloan Kettering Cancer Center | 2 | 2020-12-10 | 2025-05-28 |
| Study of Benralizumab in People With Skin Side Effects Caused by Cancer Therapies Benralizumab - Solid Tumor, Solid Carcinoma | Phase 2 | Completed | Memorial Sloan Kettering Cancer Center | 51 | 2020-09-16 | 2026-06-01 |
Showing 20 of 32. Sign in to see all of them.
Neoplasm Metastasis (9) · Neoplasms (8) · Breast Neoplasms (6) · Carcinoma, Non-Small-Cell Lung (4) · Colorectal Neoplasms (4) · Stomach Neoplasms (4) · Colonic Neoplasms (3) · Endometrial Neoplasms (3) · Ovarian Neoplasms (3) · Pancreatic Neoplasms (3) · Prostatic Neoplasms (3) · Urinary Bladder Neoplasms (3) · Brain Neoplasms (2) · Carcinoma, Renal Cell (2) · Carcinoma, Transitional Cell (2)
Neoplasms by Site (18) · Neoplasms (16) · Neoplasms by Histologic Type (12) · Neoplasms, Glandular and Epithelial (11) · Pathologic Processes (11) · Pathological Conditions, Signs and Symptoms (11) · Digestive System Diseases (10) · Carcinoma (9) · Digestive System Neoplasms (9) · Neoplastic Processes (9) · Gastrointestinal Diseases (8) · Respiratory Tract Diseases (8) · Female Urogenital Diseases (7) · Female Urogenital Diseases and Pregnancy Complications (7) · Gastrointestinal Neoplasms (7)
Fecal Microbiota Transplantation (2) · Magnetic Resonance Spectroscopy (2) · Nivolumab (2) · Specimen Handling (2) · pembrolizumab (2) · 130-nm albumin-bound paclitaxel (1) · ALX148 (1) · AZD1390 (1) · Biopsy (1) · Blood Specimen Collection (1) · Capecitabine (1) · Cetuximab (1) · Fluorouracil (1) · Fulvestrant (1) · Gemcitabine (1)
Memorial Sloan Kettering Cancer Center (6) · Aminex Therapeutics, Inc. (2) · Asan Medical Center (2) · Robert Flavell, MD, PhD (2) · Xadcera Biopharmaceutical (Suzhou) Co., Ltd. (2) · Centre Francois Baclesse (1) · Doma Biopharmaceutical（Suzhou）Co., Ltd. (1) · Genzada Pharmaceuticals USA, Inc. (1) · Hadassah Medical Organization (1) · Ikena Oncology (1) · Imugene Limited (1) · Institut Cancerologie de l'Ouest (1) · Institut de Recherches Internationales Servier (1) · Minneamrita Therapeutics LLC (1) · Odense University Hospital (1)
United States (22) · Australia (6) · Denmark (3) · France (3) · South Korea (3) · China (2) · Hong Kong (1) · Israel (1) · Italy (1) · Japan (1) · Spain (1) · United Kingdom (1)
Sook Ryun Park, M.D, Ph D (2) · Adam Schoenfeld, MD (1) · Alina Markova, MD (1) · Anish Thomas, MD (1) · Cecilia M Lund, MD, PhD (1) · Daniel Higginson, MD (1) · Ezra Rosen, MD, PhD (1) · Henrik J Ditzel, MD, DMSc (1) · Hovav Nechushtan, MD PhD (1) · Jackie Walling, MBChB PhD (1) · Jesper Ryg, MD, PhD (1) · Jianjun Liu, Ph.D. & M.D. (1) · Jordan Jacobs, MBA (1)
PMID 31680143, PMID 33888901, PMID 34176752, PMID 35276694, PMID 38008031, PMID 38758815, PMID 39059396, PMID 40382663, PMID 40913836, PMID 41469668, PMID 42208483
2025 (1), R01CA266666 (1)